医学
血脂异常
恩曲他滨
杜鲁特格拉维尔
内科学
替诺福韦-阿拉芬酰胺
拉米夫定
队列
体质指数
前瞻性队列研究
脂肪变性
重量变化
病毒载量
乙型肝炎病毒
减肥
肥胖
免疫学
人类免疫缺陷病毒(HIV)
抗逆转录病毒疗法
病毒
作者
Alejandro García García,Miguel Suárez Robles,Maria Jesús Pérez‐Elías,Eugènia Negredo,José Alcamı́,Carmen Elena Gómez Rodríguez,Patricia González‐Ruano,Miguel Alberto de Zárraga Fernández,Carlos Dueñas Gutiérrez,Santiago Moreno,Javier Martínez‐Sanz
摘要
In this nationwide cohort of ART-naive individuals, initiation of BIC/FTC/TAF or DTG + 3TC resulted in similar modest increases in weight and lipid levels after 96 weeks, with no significant differences in metabolic outcomes or clinical events. These findings suggest that the metabolic profile of TAF should not be a deciding factor when choosing between 2- and 3-drug ART regimens.
科研通智能强力驱动
Strongly Powered by AbleSci AI